Xin Ru, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · T Chow Cardiology and Electrophysiology Medical Office · Permanente Medical Group Inc
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Xin Ru’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$15,952
Medicare paid this office $15,952 for 131 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 82 | $7,309 | $72 |
| Return visit (30+ min) | 54 | $6,726 | $100 |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 78 · Women 53% · Also on Medicaid 36% · Health risk score 1.69. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Atrial fibrillation 64% · Diabetes 55% · Heart failure 48% · Chronic kidney disease 34% · Cancer 15% · Depression 13% · Stroke 11% · COPD 10%.
The office billed $55,185, Medicare allowed $20,715 and paid $15,952; for 205 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$7,896 in 2024
Medicaid paid $7,896 for 96 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 48 | $4,200 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 48 | $3,696 |
| 2024 | 96 | 2 | 22 | $7,896 |
Drugs they prescribed that Part D paid
$45,573
Pharmacies billed $45,573 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 319) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
244 generic and 75 brand-name prescriptions · $45,573 in drug cost · 20 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 40 | $20,692 | $517 |
| Pradaxa | 14 | $2,954 | $211 |
| Amiodarone | 25 | $747 | $30 |
| Furosemide | 34 | $415 | $12 |
| Metoprolol | 32 | $401 | $13 |
See all 9 drugs
| Jardiance | 40 | $20,692 | $517 |
| Pradaxa | 14 | $2,954 | $211 |
| Amiodarone | 25 | $747 | $30 |
| Furosemide | 34 | $415 | $12 |
| Metoprolol | 32 | $401 | $13 |
| Spironolactone | 27 | $323 | $12 |
| Sotalol | 13 | $275 | $21 |
| Losartan | 17 | $194 | $11 |
| Cephalexin | 16 | $135 | $8 |
Year by year
| 2024 | 319 | 183 | 0% (0) | 24% | $45,573 |
| 2023 | 11 | None | 0% (0) | None | $1,499 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$552 in 2025
| 2025 | 6 | 22 | None | $552 |
| 2024 | 6 | 15 | None | $425 |
| 2023 | 4 | 8 | None | $329 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $328 | 13 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $95 | 4 payments
|
| Amgen | Repatha | $41 | 2 payments
|
| Alnylam Pharmaceuticals | Amvuttra | $32 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $29 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
See all 22 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-01 | Kerendia | $24 |
| Novo Nordisk | Meals · 2025-11-13 | Wegovy | $22 |
| Novo Nordisk | Meals · 2025-11-05 | Wegovy | $13 |
| Novo Nordisk | Meals · 2025-10-22 | Wegovy | $25 |
| Novo Nordisk | Meals · 2025-10-13 | Wegovy | $13 |
| Novo Nordisk | Meals · 2025-09-30 | Wegovy | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-22 | Kerendia | $26 |
| Novo Nordisk | Meals · 2025-08-22 | Wegovy | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-18 | Kerendia | $25 |
| Alnylam Pharmaceuticals | Meals · 2025-07-08 | Amvuttra | $32 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-30 | Kerendia | $20 |
| Novo Nordisk | Meals · 2025-06-06 | Wegovy | $15 |
| Novo Nordisk | Meals · 2025-05-13 | Wegovy | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-05 | Jardiance | $25 |
| Novo Nordisk | Meals · 2025-05-02 | Wegovy | $12 |
| Amgen | Meals · 2025-04-28 | Repatha | $21 |
| Novo Nordisk | Meals · 2025-04-17 | Wegovy | $119 |
| Amgen | Meals · 2025-03-31 | Repatha | $20 |
| Novo Nordisk | Meals · 2025-03-17 | Wegovy | $19 |
| Novo Nordisk | Meals · 2025-02-12 | Ozempic | $13 |
| Novartis Pharmaceuticals | Meals · 2025-02-10 | Leqvio | $29 |
| Novo Nordisk | Meals · 2025-01-13 | Ozempic | $14 |
See earlier years (2024, 2023)
2024: $425
| Novo Nordisk | Ozempic | $167 | 4 payments
|
| Amgen | Repatha | $91 | 4 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $66 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $63 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $20 | 1 payment
|
| Medtronic | None | $18 | 1 payment
|
2023: $329
| Medtronic | None | $149 | 1 payment
|
| Biosense Webster | Carto 3 | $77 | 2 payments
|
| Lexicon Pharmaceuticals | Inpefa | $66 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $38 | 2 payments
|
Professional record
- NPI
- 1952008906
- Licence
- CA 95024085
- Group
- T Chow Cardiology and Electrophysiology Medical Office · Permanente Medical Group Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 312 Lester Ct, Santa Clara, CA, 95051
- NPI first listed
- 2023-02-09
- NPI last updated
- 2023-02-09
- NPI record certified
- 2023-02-09
This is when the NPI record was last certified, not a medical board exam.